Stay updated on Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    New site-wide notice about government funding and NIH operating status is displayed at the top of the page. The page header now shows a Revision: v3.4.1, replacing the previous Revision: v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:12.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option. Updated metadata to display 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' entries.
    Difference
    0.2%
    Check dated 2026-01-28T03:47:45.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. This appears to be a behind-the-scenes update with no impact on study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-01-14T02:43:15.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The Locations section was updated to add new study sites across the US, France, Japan, Russia, Spain, and the UK, and the revision version was updated to v3.3.3.
    Difference
    2%
    Check dated 2025-12-23T13:31:19.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 is shown on the page. This is a minor internal update that does not affect study content or user-facing information, and To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:45:56.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Publications section now states that entries are automatically filled from PubMed and may not all pertain to the study. Revision updated from v3.2.0 to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T14:49:35.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Hepatocellular Carcinoma Clinical Trial page.